Engineered Therapeutic Viruses can Target Abnormal RNA Splicing in Cancer
2022
Team Members:
- Benjamin Dubner
Advisors:
- Constanza Miranda, Ph.D.
Sponsors:
- William Dalton, M.D., Ph.D.
- Jonathan Ling, Ph.D.
- Fatemeh Rajaii, M.D., Ph.D.